Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.88 USD | -3.06% | -5.03% | +174.92% |
May. 28 | Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion | MT |
May. 15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 10.25 | 12.53 | 11.77 |
Spread/Res. | -13.37% | -29.13% | -24.55% |
Spread/Supp. | +13.27% | +55.79% | +87.54% |
Support | 7.840 | 5.700 | 4.735 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ARQT Stock
- Charts Arcutis Biotherapeutics, Inc.